Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Esophageal Neoplasms × Mass Screening × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Papillomavirus Infections 1 Neoplasms 1 Multiple Myeloma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Financial Stress 1 Esophageal Neoplasms 1 Breast Neoplasms 1

Interventions

pembrolizumab 10 Carboplatin 10 Paclitaxel 9 Fluorouracil 9 Oxaliplatin 8 Radiotherapy 7 Leucovorin 6 Cisplatin 6 Radiotherapy, Intensity-Modulated 5 Nivolumab 5 tislelizumab 3 durvalumab 3 Taxes 3 Magnetic Resonance Spectroscopy 3 Trastuzumab 2 Surgical Procedures, Operative 2 Radiation 2 Proton Therapy 2 Irinotecan 2 Fluorodeoxyglucose F18 2 Drug Therapy 2 Docetaxel 2 Cetuximab 2 Capecitabine 2 Blood Specimen Collection 2 zimberelimab 1 zanidatamab 1 tucatinib 1 squamous cell carcinoma-related antigen 1 sintilimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06335966 2026-03-17

BEST-RPP

OHSU Knight Cancer Institute

Active not recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡